Coya Therapeutics shares rose after the company entered into definitive securities purchase agreements for the purchase and sale of 1.4 million shares in a private placement at $7.25 a share. Shares ...
BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...
Canada-focused AuMEGA Metals (formerly Matador Mining) said on Friday that it was in the process of arranging a private placement of $10-million. The ASX- and TSX-listed company would use the proceeds ...
The Offering is expected to close following receipt of conditional approval of the TSX Venture Exchange (" TSXV "). All securities issued under the Offering will be subject to a hold period in Canada ...
BioAffinity Technologies shares declined after the company announced a $2.66 million registered direct offering of stock and a concurrent private placement of warrants. Shares were down 25%, to $1.59, ...
Results that may be inaccessible to you are currently showing.